Royalty Pharma PLC (RPRX) Dividends

RPRX Price Forecast Based on Dividend Discount Model

A technique commonly used by dividend investors to value dividend-issuing stocks is the Dividend Discount Model (DDM), which seeks to determine a fair share price based on the dividend provided by the company relative to a number of other company-specific factors. Regarding Royalty Pharma plc, the dividend discount model StockNews created for the company implies a positive return of 17.15%. Digging deeper, the aspects of Royalty Pharma plc's dividend discount model that we found most interesting were:

• Beta is a measure of how volatile a stock is relative to the S&P 500; when evaluated against its peers in the mid-sized revenue class, Royalty Pharma plc has a beta lower than 70.37% of such peers.
• In terms of who is growing the amount of dividends they return to shareholders, RPRX boasts a higher growth rate in terms of its annual cash distributed to its owners than only 1.3% of the dividend issuers in our set.

RPRX Dividends vs. Peers